APA (7th ed.) Citation

M, A., D, D., L, L., S, H., A, G., G, H., . . . CQ, S. (2022). Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation. Journal of immunology (Baltimore, Md. : 1950), 208(5), 1248. https://doi.org/10.4049/jimmunol.2100031

Chicago Style (17th ed.) Citation

M, Anliker, et al. "Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation." Journal of Immunology (Baltimore, Md. : 1950) 208, no. 5 (2022): 1248. https://doi.org/10.4049/jimmunol.2100031.

MLA (9th ed.) Citation

M, Anliker, et al. "Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation." Journal of Immunology (Baltimore, Md. : 1950), vol. 208, no. 5, 2022, p. 1248, https://doi.org/10.4049/jimmunol.2100031.